134 related articles for article (PubMed ID: 16326101)
1. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
Hering KW; Artz JD; Pearson WH; Marletta MA
Bioorg Med Chem Lett; 2006 Feb; 16(3):618-21. PubMed ID: 16326101
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
Martin NI; Derbyshire ER; Marletta MA
Bioorg Med Chem Lett; 2007 Sep; 17(17):4938-41. PubMed ID: 17587571
[TBL] [Abstract][Full Text] [Related]
3. Resonance Raman study on synergistic activation of soluble guanylate cyclase by imidazole, YC-1 and GTP.
Pal B; Li Z; Ohta T; Takenaka S; Tsuyama S; Kitagawa T
J Inorg Biochem; 2004 May; 98(5):824-32. PubMed ID: 15134928
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.
Lee FY; Lien JC; Huang LJ; Huang TM; Tsai SC; Teng CM; Wu CC; Cheng FC; Kuo SC
J Med Chem; 2001 Oct; 44(22):3746-9. PubMed ID: 11606139
[TBL] [Abstract][Full Text] [Related]
7. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
Martin E; Lee YC; Murad F
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12938-42. PubMed ID: 11687640
[TBL] [Abstract][Full Text] [Related]
8. Soluble guanylate cyclase: effect of YC-1 on ligation kinetics with carbon monoxide.
Sharma VS; Magde D; Kharitonov VG; Koesling D
Biochem Biophys Res Commun; 1999 Jan; 254(1):188-91. PubMed ID: 9920755
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of carbon monoxide-induced relaxation of rat aorta by YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole].
McLaughlin BE; Chretien ML; Choi C; Brien JF; Nakatsu K; Marks GS
Can J Physiol Pharmacol; 2000 Apr; 78(4):343-9. PubMed ID: 10772062
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat.
Mizusawa H; Hedlund P; Brioni JD; Sullivan JP; Andersson KE
J Urol; 2002 May; 167(5):2276-81. PubMed ID: 11956492
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1.
Kharitonov VG; Sharma VS; Magde D; Koesling D
Biochemistry; 1999 Aug; 38(33):10699-706. PubMed ID: 10451364
[TBL] [Abstract][Full Text] [Related]
13. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
14. Activation of soluble guanylyl cyclase inhibits estradiol production and cyclic AMP accumulation from cultured rat granulosa cells.
Tafoya MA; Chen JY; Stewart RL; Lapolt PS
Fertil Steril; 2004 Oct; 82 Suppl 3():1154-9. PubMed ID: 15474089
[TBL] [Abstract][Full Text] [Related]
15. Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines.
Lee SJ; Kim YJ; Lee CS; Bae J
Chem Biol Interact; 2009 Oct; 181(2):185-92. PubMed ID: 19481069
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
Friebe A; Koesling D
Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
[TBL] [Abstract][Full Text] [Related]
17. Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction.
Brioni JD; Nakane M; Hsieh GC; Moreland RB; Kolasa T; Sullivan JP
Int J Impot Res; 2002 Feb; 14(1):8-14. PubMed ID: 11896472
[TBL] [Abstract][Full Text] [Related]
18. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide relaxes the female pig urethra as effectively as nitric oxide in the presence of YC-1.
Schroder A; Hedlund P; Andersson KE
J Urol; 2002 Apr; 167(4):1892-6. PubMed ID: 11912455
[TBL] [Abstract][Full Text] [Related]
20. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]